Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial

Conclusions: Treatment with fluvoxamine (100 mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19, reduced the need for extended emergency room observation or hospitalization.

https://www.medrxiv.org/content/10.1101/2021.08.19.21262323v1?fbclid=IwAR3AKHyRhMqBXlEfJLpJFntm3ZWAeBsUUCJ9UcaClk4VhK1UCpRkvHSqZ7I